ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,383,616, issued on Aug. 12, was assigned to IMMUNE-PATH BIOTECHNOLOGY (SUZHOU) Co. LTD. (Jiangsu, China).
"Recombinant herpes zoster vaccine composition and application thereof" was invented by Li Shi (Shanghai), Zhi Zhang (Shanghai), Wenli Tian (Shanghai), Lin Liu (Shanghai), Xiaodong Sun (Shanghai), Wei Yang (Shanghai) and Wei Li (Shanghai).
According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed in the present invention are a recombinant herpes zoster vaccine composition and an application thereof. Compared with other combinations of antigens and adjuvants, the novel vaccine composition provided by the present invention has a more beneficial immune ef...